Active, Not Recruiting
An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
NCT05900141
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hyperlipidemias, +5 more
- Locations
-
- Novartis Investigative Site Frankfurt am Main, Hesse, Germany
- Novartis Investigative Site Berlin, Germany
- Novartis Investigative Site Cloppenburg, Germany
- Novartis Investigative Site Dresden, Germany